Infusion therapy for working families. Nationwide network of infusion providers at transparent, wholesale drug prices. Supported with Leap Care Guides to provide excellent patient care.

Building category defining businesses that improve lives.

Advised CEO of Risalto, a comprehensive provider of MSK care on business model transformation, go to market strategy, and recapitalization. Supported market diligence, business development, and value based contracting activities. Led fundraising efforts and negotiations with top tier private equity investor, culminating in $53m investment.

I advise and support hospital executives and clinical leaders who seek to optimize their drug and device spend - maximizing clinical outcomes while also eliminating waste in order to improve financial performance.Lumere (formerly Procured Health) offers innovative technology solutions and services to help hospitals eliminate costly and unnecessary variation. Our clients are some of the most recognized health systems in the U.S., all of whom share a commitment to providing their patients maximum value.

- Developed US commercial growth strategy for large medical device company, including business model transformation- Supported development of McKinsey’s think tank devoted to U.S. health system reform. Prepared intelligence briefs on key regulatory decisions, authored a primer on the implications of reform across the industry, key success factors, and remaining uncertainties. Designed employer behavior tracker to provide payors and providers improved visibility on coverage changes.- Defined operating strategy to accelerate growth of a multinational medical device company in MENA - Developed an operating model for a multinational pharmaceutical company to drive growth in Tier 2/3 emerging markets- Prepared an investment strategy for a large Middle Eastern strategic investment fund, including comprehensive scan of industry verticals and development of business cases for investments in pediatric hospitals, polyclinics, and large integrated provider networks- Supported implementation of a growth strategy for a generics pharmaceutical company, including change team design and recruitment, comprehensive roadmap of key activities and deliverables, and capability building initiatives- Assessed efficiency and efficacy of health system financing in a GCC country. Evaluated drivers of healthcare spend, impact of supply growth on future costs, and recommended reforms at the payor, provider, and consumer level to curtail growth in health costs- Evaluated the viability and strategy of hospital privatization in a GCC country and supported negotiations with a large private operator by identifying opportunities to improve financial performance

- Founded nonprofit, 501(c)(3) organization that aspires to improve the lives of the world's poorest while exposing undergraduates to the ongoing challenges of international development. - Developed organization's mission, vision, strategy, and financial projections in a comprehensive business planc- Obtained endorsements and letters of support from United Nations Development Programme, United Nations, and the Harvard Committee on Human Rights Studies - Recruited Board of Directors that includes renowned Harvard professors, leaders of national and international non-profit organizations, and socially responsible business leaders- Raised over $150,000 to help cover both administrative and program expenses; received $50,000 grant from the Bill & Melinda Gates Foundation

- Analyzed and reported to senior management on investment opportunities in oil and gas and renewable energy sectors- Drafted business strategy on joint venture opportunity in Saudi Arabia which received Board approval- Developed financial model comparing methods of reducing subsidiary's coal procurement costs - Assisted outside legal counsel in the due diligence of a transaction involving European windfarms- Drafted portions of a business description in relation to a medium term note program that is the largest undertaken by a Middle Eastern company